Financials
Income statement
| Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|
| Total reported revenue | 7.7B | 6.4B | 6.5B | 6.3B |
| Cost of revenue | — | — | — | — |
| Gross profit | — | — | — | — |
| Operating expense | ||||
| Research & development | — | — | — | — |
| Selling general and admin | — | — | — | — |
| Other operating expenses | 4.4B | -12.0B | 3.9B | -4.0B |
| Operating income | — | — | — | — |
| Non operating interest income | ||||
| Income | — | — | — | — |
| Expense | — | — | — | — |
| Other income expense | — | — | — | — |
| Pretax income | 2.7B | 1.7B | 2.2B | 1.9B |
| Tax provision | 621M | 448M | 412M | 427M |
| Net income | 2.1B | 1.2B | 1.8B | 1.5B |
| Basic EPS | — | 0.1 | 0.1 | — |
| Diluted EPS | — | 0.1 | 0.1 | — |
| Basic average shares | — | 14.4B | 14.6B | — |
| Diluted average shares | — | 14.4B | 14.6B | — |
| EBITDA | — | — | — | — |
| Net income from continuing op. | — | — | — | — |
| Minority interests | -2M | -20M | -3M | -23M |
| Preferred stock dividends | 232M | 228M | 253M | 251M |